Evaluating Herpes Zoster Risk Across Targeted Therapies in RA: JAK Inhibitors Versus TNF Inhibitors.

Authors

• Enmanuel Hernandez, Florida International UniversityFollow

Files

Publication Date

4-30-2026

Content Type

poster_control

Recommended Citation

Hernandez, Enmanuel, "Evaluating Herpes Zoster Risk Across Targeted Therapies in RA: JAK Inhibitors Versus TNF Inhibitors." (2026). 2026 Baptist Health Academic Conference: The Art and Science of Interprofessional Collaborations. 96.
https://scholarlycommons.baptisthealth.net/bhsf-academic-week-2026/96